Skip to content

INTRA-ARTICULAR VERSUS SUBCHONDRAL VERSUS INTRA-ARTICULAR PLUS SUBCHONDRAL PB-MSCs IN PRIMARY OA KNEE

COMPARATIVE OUTCOME ANALYSIS OF INTRA-ARTICULAR VERSUS SUBCHONDRAL VERSUS INTRA-ARTICULAR PLUS SUBCHONDRAL INJECTION OF PERIPHERAL BLOOD-DERIVED MESENCHYMAL STROMAL CELLS (PB-MSCs) IN PRIMARY OSTEOARTHRITIS OF KNEE- A DOUBLE-BLINDED, UNICENTRIC, RANDOMISED CONTROLLED TRIAL - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097029
Enrollment
150
Registered
2025-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

Intervention1: Nil: Nil

Sponsors

DR HARISH V K RATNA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with radiological primary osteoarthritis of knees-Kellgren Lawrence grade 2 and 3 based on x-ray findings, Patients with severe pain and under anti-inflammatory treatment without improvement more than 3 months, Patients who have given consent for treatment as per our protocol

Exclusion criteria

Exclusion criteria: Patients with primary osteoarthritis of knees- Kellgren Lawrence grade 1 and 4 based on x-ray findings and secondary osteoarthritis of knees, History of prior corticosteroid injection at a treatment site within 3 months of duration, Rheumatoid arthritis, inflammatory arthritis or polyarticular arthritis, and autoimmune diseases, Haemoglobin less than 10 gram and platelet count less than 105 per microlitre, Patients with local infection at the site of the procedure, HIV, Hepatitis B or C, septicaemia, other systemic metabolic disorders, bleeding, and other coagulation disorders

Design outcomes

Primary

MeasureTime frame
Pain reliefTimepoint: Day 0, at the end of 1,3,6,12 and 24months

Secondary

MeasureTime frame
Healing of subchondral bone lesionsTimepoint: Day 0, at the end of 1,3,6,12 and 24months;Integrity of cartilageTimepoint: Day 0, at the end of 1,3,6,12 and 24months

Countries

India

Contacts

Public ContactDr Madhan Jeyaraman

Sri Lalithambigai Medical College and Hospital

madhanjeyaraman@gmail.com8310600785

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026